Orphan drugs can be defined as a molecule intended to treat a rare disease. The rare disease, as name suggests, has low prevalence rate and has been defined differently across the geographical locations. Each country has at the least one organization, which has been supporting the patients suffering from rare diseases. The need is to generate enough orphan drugs’ availability to the needful for the intended treatment, across the world. From the company's perspective, there is increased focus by drug manufacturers, each year, on the development of therapies for orphan indications, as well as, explore the expansion opportunities across the world. The market report discusses the market aspects related to each market, segmentation, and major geographies across world. The market size can be evaluated by collating the revenues generated from various segments and their usage across the various end-user industries, along with the costs associated with products. The definitions for individual segments have been provided in the respective segments. The market estimates provided in this report are entirely based on the segments tracked in this report.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET INSIGHTS

5. MARKET SEGMENTATION

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIES AND FUTURE TRENDS